Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Elaine Lam

Concepts (283)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
36
2025
179
7.520
 Why?
Kidney Neoplasms
39
2025
348
6.980
 Why?
Prostatic Neoplasms
13
2023
998
2.990
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
70
1.540
 Why?
Antineoplastic Agents
15
2024
2046
1.410
 Why?
Antibodies, Monoclonal, Humanized
11
2025
757
1.240
 Why?
Prostate-Specific Antigen
4
2023
160
1.220
 Why?
Antineoplastic Combined Chemotherapy Protocols
15
2025
1560
1.150
 Why?
Neoplasms
10
2023
2455
1.030
 Why?
Testicular Neoplasms
3
2023
102
0.970
 Why?
Protein Kinase Inhibitors
11
2021
887
0.970
 Why?
Antineoplastic Agents, Immunological
2
2025
181
0.910
 Why?
Carcinoma, Transitional Cell
4
2025
59
0.850
 Why?
Seminoma
2
2021
18
0.840
 Why?
Carcinoma, Medullary
2
2013
14
0.770
 Why?
Retroperitoneal Neoplasms
1
2021
25
0.720
 Why?
Aged
35
2025
22061
0.710
 Why?
Urinary Bladder Neoplasms
4
2025
226
0.710
 Why?
Male
58
2025
63670
0.700
 Why?
Teratoma
1
2021
103
0.680
 Why?
Pneumocystis carinii
1
2020
11
0.670
 Why?
Spinal Cord Compression
1
2020
18
0.670
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2020
38
0.670
 Why?
Pneumonia, Pneumocystis
1
2020
36
0.660
 Why?
Euterpe
1
2018
4
0.610
 Why?
Humans
82
2025
129625
0.600
 Why?
Pyrazoles
3
2022
404
0.580
 Why?
TWEAK Receptor
1
2017
5
0.580
 Why?
Prednisone
3
2020
234
0.570
 Why?
Sulfonamides
3
2015
497
0.550
 Why?
Middle Aged
36
2025
31136
0.550
 Why?
Abiraterone Acetate
1
2017
14
0.540
 Why?
Plant Extracts
1
2018
199
0.520
 Why?
Adrenal Cortex Hormones
1
2020
524
0.520
 Why?
Neoplasm Recurrence, Local
3
2023
958
0.520
 Why?
Pyridines
4
2021
478
0.510
 Why?
Antineoplastic Agents, Hormonal
2
2015
155
0.500
 Why?
Neoplasm Metastasis
9
2020
611
0.500
 Why?
Brain Neoplasms
2
2021
1145
0.490
 Why?
Carcinoma, Papillary
1
2015
77
0.480
 Why?
Patient Reported Outcome Measures
4
2025
374
0.470
 Why?
Everolimus
2
2025
88
0.460
 Why?
Paclitaxel
3
2022
217
0.450
 Why?
Prostatic Neoplasms, Castration-Resistant
3
2022
45
0.440
 Why?
Aged, 80 and over
16
2025
7052
0.440
 Why?
Interleukin-2
2
2014
437
0.430
 Why?
Neoplasms, Complex and Mixed
1
2013
7
0.430
 Why?
Antibodies, Monoclonal
2
2017
1366
0.420
 Why?
Retrospective Studies
18
2024
14522
0.410
 Why?
Treatment Outcome
17
2025
10219
0.400
 Why?
Biomarkers, Tumor
5
2016
1164
0.400
 Why?
Urologic Neoplasms
2
2025
26
0.400
 Why?
Nephrectomy
4
2024
158
0.380
 Why?
Carcinoma, Non-Small-Cell Lung
3
2025
1049
0.380
 Why?
Epothilones
1
2011
1
0.380
 Why?
Angiomyolipoma
1
2011
17
0.370
 Why?
Basic Helix-Loop-Helix Transcription Factors
3
2024
235
0.370
 Why?
Androgen Antagonists
3
2020
79
0.370
 Why?
Deoxycytidine
2
2010
164
0.360
 Why?
Multicenter Studies as Topic
1
2012
286
0.360
 Why?
Anilides
4
2021
70
0.350
 Why?
Lung Neoplasms
4
2025
2342
0.350
 Why?
Benzenesulfonates
1
2010
19
0.340
 Why?
Suramin
1
2010
8
0.340
 Why?
Radiosurgery
3
2019
321
0.320
 Why?
Maximum Tolerated Dose
6
2022
193
0.310
 Why?
Adult
25
2025
35599
0.310
 Why?
Immunotherapy
5
2024
596
0.310
 Why?
Indenes
2
2025
5
0.290
 Why?
Disease Progression
3
2021
2627
0.290
 Why?
Fluorouracil
1
2008
197
0.290
 Why?
Bone Neoplasms
2
2023
229
0.280
 Why?
Female
33
2025
68734
0.280
 Why?
Quinazolines
1
2008
243
0.270
 Why?
Neoplasm Staging
7
2017
1282
0.270
 Why?
Chemotherapy, Adjuvant
3
2013
377
0.270
 Why?
Platinum
2
2024
44
0.260
 Why?
Thyroid Neoplasms
1
2010
312
0.260
 Why?
Drug Administration Schedule
3
2021
767
0.250
 Why?
Prognosis
5
2023
3774
0.240
 Why?
Sulfones
2
2017
108
0.240
 Why?
Phenylurea Compounds
4
2016
88
0.240
 Why?
Ipilimumab
2
2021
31
0.220
 Why?
Benzoxazoles
2
2022
20
0.220
 Why?
Melanoma
2
2025
730
0.210
 Why?
Taxoids
2
2017
98
0.210
 Why?
Bevacizumab
2
2020
128
0.200
 Why?
Multiple Sclerosis
2
2019
438
0.200
 Why?
Kaplan-Meier Estimate
5
2024
851
0.200
 Why?
Mastectomy
1
2023
132
0.200
 Why?
Pyrimidines
3
2022
459
0.190
 Why?
Quantitative Trait Loci
1
2024
353
0.190
 Why?
Administration, Oral
4
2024
787
0.180
 Why?
Remission, Spontaneous
1
2021
38
0.180
 Why?
Biliary Tract Neoplasms
1
2021
25
0.180
 Why?
Quality of Life
2
2025
2688
0.180
 Why?
Celecoxib
2
2012
39
0.180
 Why?
Carboplatin
1
2021
139
0.170
 Why?
Neoplasm, Residual
1
2021
121
0.170
 Why?
Phosphatidylinositol 3-Kinases
1
2022
361
0.170
 Why?
Syndrome
1
2021
340
0.170
 Why?
Proto-Oncogene Proteins c-akt
1
2022
432
0.170
 Why?
Combined Modality Therapy
4
2019
1203
0.170
 Why?
TOR Serine-Threonine Kinases
1
2022
398
0.160
 Why?
Azepines
1
2020
88
0.160
 Why?
Cancer Care Facilities
1
2020
32
0.160
 Why?
Thrombosis
1
2023
348
0.160
 Why?
Antiemetics
1
2020
41
0.160
 Why?
Homologous Recombination
1
2019
23
0.160
 Why?
Fatal Outcome
1
2020
300
0.160
 Why?
Morpholines
1
2020
122
0.160
 Why?
MAP Kinase Kinase Kinases
1
2019
70
0.160
 Why?
Disease-Free Survival
4
2016
646
0.150
 Why?
Fruit and Vegetable Juices
1
2018
14
0.150
 Why?
Drug Hypersensitivity
1
2020
81
0.150
 Why?
Feedback
1
2019
162
0.150
 Why?
Liver Neoplasms
1
2023
639
0.150
 Why?
Diagnosis, Computer-Assisted
1
2019
86
0.150
 Why?
Cost-Benefit Analysis
1
2021
569
0.140
 Why?
Neoplastic Cells, Circulating
2
2016
70
0.140
 Why?
Indans
1
2017
11
0.140
 Why?
Interferon beta-1b
1
2017
2
0.140
 Why?
Niacinamide
3
2016
75
0.140
 Why?
Genome-Wide Association Study
1
2024
1326
0.140
 Why?
Proton Therapy
1
2017
12
0.140
 Why?
Erythrocytes, Abnormal
1
2016
11
0.130
 Why?
DNA Damage
1
2019
384
0.130
 Why?
Nanoparticles
1
2021
375
0.130
 Why?
Neoadjuvant Therapy
2
2023
379
0.130
 Why?
Cell Line, Tumor
3
2020
3186
0.130
 Why?
Polymorphism, Single Nucleotide
1
2024
2060
0.130
 Why?
Multiple Sclerosis, Relapsing-Remitting
1
2017
73
0.130
 Why?
Dose-Response Relationship, Drug
3
2022
2011
0.130
 Why?
Hematologic Diseases
1
2016
62
0.130
 Why?
Autoimmune Diseases
1
2020
427
0.130
 Why?
Oncolytic Virotherapy
1
2015
13
0.130
 Why?
Indazoles
2
2015
66
0.130
 Why?
Mammalian orthoreovirus 3
1
2015
37
0.120
 Why?
Problem Solving
1
2017
155
0.120
 Why?
Genetic Predisposition to Disease
1
2024
2274
0.120
 Why?
Pyrroles
1
2016
202
0.120
 Why?
Fatigue
2
2022
318
0.120
 Why?
Angiopoietin-1
1
2015
11
0.120
 Why?
Angiopoietin-2
1
2015
15
0.120
 Why?
Imidazoles
2
2015
234
0.120
 Why?
Receptor, IGF Type 1
1
2015
64
0.120
 Why?
Kidney Glomerulus
1
2015
109
0.120
 Why?
Magnetic Resonance Imaging
2
2021
3394
0.110
 Why?
Radiation Tolerance
1
2015
98
0.110
 Why?
Practice Guidelines as Topic
2
2020
1501
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2015
259
0.110
 Why?
Soft Tissue Neoplasms
1
2015
111
0.110
 Why?
Prefrontal Cortex
1
2017
305
0.110
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2013
107
0.110
 Why?
Indoles
1
2016
383
0.110
 Why?
Patient Satisfaction
1
2017
633
0.100
 Why?
Prostatectomy
1
2013
103
0.100
 Why?
Glycine
1
2014
165
0.100
 Why?
Cohort Studies
5
2021
5426
0.100
 Why?
Recombinant Fusion Proteins
1
2015
651
0.100
 Why?
Quinolines
1
2013
156
0.100
 Why?
Glomerular Filtration Rate
1
2015
712
0.090
 Why?
Tubulin Modulators
1
2011
9
0.090
 Why?
Emotions
1
2017
545
0.090
 Why?
Algorithms
1
2019
1616
0.090
 Why?
Metabolic Clearance Rate
1
2011
117
0.090
 Why?
Severity of Illness Index
1
2019
2739
0.090
 Why?
Arthralgia
1
2011
49
0.090
 Why?
Breast Neoplasms
1
2023
2133
0.090
 Why?
Clinical Trials as Topic
1
2015
1005
0.090
 Why?
Area Under Curve
1
2011
304
0.090
 Why?
Mechanistic Target of Rapamycin Complex 1
2
2022
119
0.090
 Why?
Peripheral Nervous System Diseases
1
2011
125
0.090
 Why?
Diarrhea
1
2011
182
0.090
 Why?
Survival Rate
3
2020
1872
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2010
30
0.080
 Why?
Molecular Structure
1
2011
481
0.080
 Why?
Tomography, X-Ray Computed
3
2022
2512
0.080
 Why?
Anti-Bacterial Agents
1
2020
1705
0.080
 Why?
Biopsy
1
2013
1088
0.080
 Why?
Decision Making
1
2017
863
0.080
 Why?
Nomograms
1
2010
47
0.080
 Why?
Radiotherapy, Adjuvant
1
2010
208
0.080
 Why?
Immunohistochemistry
1
2013
1685
0.080
 Why?
Drug Synergism
1
2010
370
0.080
 Why?
Infusions, Intravenous
1
2010
399
0.080
 Why?
Capecitabine
1
2008
45
0.080
 Why?
Positron-Emission Tomography
1
2010
282
0.070
 Why?
Proteinuria
1
2008
92
0.070
 Why?
Hypertension, Pregnancy-Induced
1
2008
68
0.070
 Why?
Young Adult
4
2024
12455
0.070
 Why?
Follow-Up Studies
3
2020
4894
0.070
 Why?
Creatinine
1
2008
490
0.060
 Why?
Risk
1
2008
855
0.060
 Why?
Urothelium
1
2025
37
0.060
 Why?
Risk Factors
2
2020
9786
0.060
 Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2024
15
0.060
 Why?
Cytoreduction Surgical Procedures
1
2024
59
0.060
 Why?
Prospective Studies
3
2021
7135
0.050
 Why?
Mastectomy, Segmental
1
2023
86
0.050
 Why?
Adjuvants, Immunologic
1
2024
221
0.050
 Why?
RNA Interference
1
2024
450
0.050
 Why?
Cardiovascular Diseases
1
2014
2006
0.050
 Why?
Disease Management
2
2017
588
0.050
 Why?
RNA, Small Interfering
1
2024
591
0.050
 Why?
Cisplatin
1
2023
299
0.050
 Why?
Nephritis, Interstitial
1
2020
13
0.040
 Why?
International Agencies
1
2020
29
0.040
 Why?
Aurora Kinase A
1
2020
54
0.040
 Why?
Drug Evaluation
1
2020
82
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Lymphocytes
1
2022
378
0.040
 Why?
Nausea
1
2020
111
0.040
 Why?
Medical Oncology
1
2022
269
0.040
 Why?
Time Factors
1
2010
6555
0.040
 Why?
Vomiting
1
2020
129
0.040
 Why?
Lymphatic Metastasis
1
2020
320
0.040
 Why?
Sex Factors
1
2025
1970
0.040
 Why?
Mutation
1
2010
3717
0.040
 Why?
Hospitals
1
2023
637
0.040
 Why?
Central Nervous System
1
2020
255
0.040
 Why?
B7-H1 Antigen
1
2020
198
0.040
 Why?
United States
2
2017
13871
0.040
 Why?
Databases, Factual
1
2023
1269
0.040
 Why?
Genetic Testing
1
2020
430
0.030
 Why?
Retreatment
1
2017
70
0.030
 Why?
Xenograft Model Antitumor Assays
1
2020
808
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
43
0.030
 Why?
Drug Therapy, Combination
1
2020
1042
0.030
 Why?
Academic Medical Centers
1
2020
475
0.030
 Why?
Receptor Protein-Tyrosine Kinases
1
2019
231
0.030
 Why?
Erythrocyte Indices
1
2016
27
0.030
 Why?
Clinical Decision-Making
1
2019
301
0.030
 Why?
Case-Control Studies
1
2024
3378
0.030
 Why?
Anti-Inflammatory Agents
1
2020
482
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2019
253
0.030
 Why?
Neutrophils
1
2022
1210
0.030
 Why?
Abdominal Neoplasms
1
2015
34
0.030
 Why?
Thoracic Neoplasms
1
2015
35
0.030
 Why?
Tosyl Compounds
1
2015
15
0.030
 Why?
Antibodies, Neoplasm
1
2015
34
0.030
 Why?
Drug Resistance, Neoplasm
1
2020
752
0.030
 Why?
Reaction Time
1
2017
417
0.030
 Why?
Kidney Function Tests
1
2015
152
0.030
 Why?
Craniocerebral Trauma
1
2017
151
0.030
 Why?
Angiogenesis Inhibitors
1
2016
219
0.030
 Why?
Neoplasm Grading
1
2015
282
0.030
 Why?
Radiotherapy
1
2015
185
0.030
 Why?
Organ Size
1
2015
446
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2015
124
0.030
 Why?
Postoperative Period
1
2015
330
0.030
 Why?
Demography
1
2015
279
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2015
129
0.030
 Why?
Nitriles
1
2015
170
0.030
 Why?
STAT5 Transcription Factor
1
2014
48
0.030
 Why?
Recurrence
1
2017
1011
0.030
 Why?
Analysis of Variance
1
2017
1293
0.030
 Why?
Drug Interactions
1
2015
395
0.030
 Why?
Gonadotropin-Releasing Hormone
1
2015
205
0.030
 Why?
Longitudinal Studies
1
2020
2720
0.020
 Why?
Medication Adherence
1
2017
558
0.020
 Why?
Proportional Hazards Models
1
2015
1198
0.020
 Why?
ErbB Receptors
1
2015
607
0.020
 Why?
Cell Survival
1
2015
1076
0.020
 Why?
Neuropsychological Tests
1
2017
1017
0.020
 Why?
Double-Blind Method
1
2016
1875
0.020
 Why?
T-Lymphocytes, Regulatory
1
2014
373
0.020
 Why?
Molecular Targeted Therapy
1
2014
391
0.020
 Why?
Biomarkers
1
2022
3968
0.020
 Why?
Enzyme Inhibitors
1
2014
827
0.020
 Why?
Proto-Oncogene Proteins
1
2014
636
0.020
 Why?
Cell Cycle Proteins
1
2014
584
0.020
 Why?
Logistic Models
1
2015
1986
0.020
 Why?
Reagent Strips
1
2008
6
0.020
 Why?
Urinalysis
1
2008
75
0.020
 Why?
Albuminuria
1
2008
183
0.020
 Why?
Diagnostic Tests, Routine
1
2008
104
0.020
 Why?
Animals
2
2020
35391
0.010
 Why?
Sensitivity and Specificity
1
2008
1843
0.010
 Why?
Mice
1
2020
16961
0.010
 Why?
Adolescent
1
2020
20412
0.010
 Why?
Signal Transduction
1
2014
4931
0.010
 Why?
Pregnancy
1
2008
6417
0.010
 Why?
Lam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (283) concept(s)
_
Co-Authors Expand Description
See all (46) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)